Sign up to save your podcasts
Or
Share 112. Facebook weaves into Wayfarers, Amazon delivers telehealth, tuition and TVs, and Google hawks hybrid hardware
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
112. Facebook weaves into Wayfarers, Amazon delivers telehealth, tuition and TVs, and Google hawks hybrid hardware
It's September, which means the start to a flurry of holiday-ready products against a backdrop of other tech company moves. In this episode, we start out assessing Facebook's stylish but functionally modest smart glasses developed with Ray-Ban. Next, we look at Amazon's many recent moves, including expanding Amazon Care, equipping more Whole Foods for cashierless checkout, offering college tuition for its 750,000 hourly workers, releasing new smart TVs, and updating its Luna streaming game service.
We also look at Google's recent hybrid work devices and partnerships with Logitech and Cisco connected to its Workspace updates. And finally, an update on tech company culture as Microsoft indefinitely delays a return to work and the first Theranos trial takes on "fake it til you make it."
Join Shawn DuBravac of Avrio Institute and Ross Rubin of Reticle Research as they dig deep into tech news in every episode of Techspansive!
View all episodes
By techspansive
5
55 ratings
It's September, which means the start to a flurry of holiday-ready products against a backdrop of other tech company moves. In this episode, we start out assessing Facebook's stylish but functionally modest smart glasses developed with Ray-Ban. Next, we look at Amazon's many recent moves, including expanding Amazon Care, equipping more Whole Foods for cashierless checkout, offering college tuition for its 750,000 hourly workers, releasing new smart TVs, and updating its Luna streaming game service.
We also look at Google's recent hybrid work devices and partnerships with Logitech and Cisco connected to its Workspace updates. And finally, an update on tech company culture as Microsoft indefinitely delays a return to work and the first Theranos trial takes on "fake it til you make it."
Join Shawn DuBravac of Avrio Institute and Ross Rubin of Reticle Research as they dig deep into tech news in every episode of Techspansive!